ナミキ商事株式会社 医薬品及び創薬化学品の専門商社

医薬品及び創薬化学品の専門商社

検索検索

バイオ製品Bio Products

タンパク質、抗体、アッセイキット

タンパク質カタログ

輸入に関する法規制チェックは、御見積のご依頼をいただいた際に行います。
法規制によっては、定価として記載の価格に追加の費用が発生する場合や供給出来ない場合がございますので、あらかじめご了承ください。

サプライヤー
TargteMol
カタログNo.
TMPY-03661
製品名称
MERS-CoV Spike Protein (S1+S2 ECD, aa 1-1297, His)
タンパク質名
MERS-CoV Spike
Species
MERS-CoV
HOST
Baculovirus Insect Cells
100μg: -
お問い合わせ

Overview

Synonyms coronavirus spike Protein, MERS-CoV, ncov spike Protein, MERS-CoV, coronavirus s1 Protein, MERS-CoV, ncov RBD Protein, MERS-CoV, cov spike Protein, MERS-CoV, ncov s2 Protein, MERS-CoV, coronavirus s2 Protein, MERS-CoV, RBD Prote, ncov s1 Protein, MERS-CoV
Characteristics Measured by its binding ability in a functional ELISA.1. Immobilized Sh(2C-EMC)(1-1297) at 10 μg/mL (100 μl/well) can bind biotinylated DPP4 , the EC50 of can biotinylated DPP4 is 0.02-0.04 ug/mL.2. Immobilized Sh(2C-EMC)(1-1297) at 10 μg/mL (100 μl/well) can bind biotinylated Fc-DPP4 , the EC50 of can biotinylated Fc-DPP4 is 0.01-0.02 ug/mL.
Endotoxin Level < 1.0 EU/μg of the protein as determined by the LAL method.
Purity 82.90%
Description MERS-CoV Spike Protein (S1+S2 ECD, aa 1-1297, His) is expressed in Baculovirus insect cells with His tag. The predicted molecular weight is 44.10 kDa and the accession number is K0BRG7.
Reference Du L,et al. (2009) The spike protein of SARS-CoV--a target for vaccine and therapeutic development. Nat Rev Microbiol. 7 (3): 226-36.,Xiao X,et al. (2004) The SARS-CoV S glycoprotein. Cell Mol Life Sci. 61 (19-20): 2428-30.,Shen S,et al. (2007) Expression, glycosylation, and modification of the spike (S) glycoprotein of SARS CoV. Methods Mol Biol. 379: 127-35.
URL https://www.targetmol.com/recombinant-protein/mers_cov_spike_protein_s1_s2_ecd_aa_1_1297_his_tag_

お問い合わせリスト(-)

お問い合わせフォーム